Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery

NCT: NCT05886218 · COMPLETED

NCT IDNCT05886218
StatusCOMPLETED
Start Date2024-01-08
Completion2025-08-27
SponsorUniversity of California, Davis (OTHER)
First posted
Last updated

Brief Summary

This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑